Funds holding BEONE MEDICINES LTD
- Declaring funds
- 116
- Of which ETFs
- 19 97 other funds
- Declared value
- 4.2B $ 280.5M SEK
- ISIN
- US07725L1026
Other lines from the same issuer : BeOne Medicines Ltd (CH1391448177), BeOne Medicines Ltd (CNE100005XT6)
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 101 | Biotechnology Fund Rydex Variable Trust | 829 | 246.2K $ | 2.31 % | as of Mar 31, 2026 ↗ |
| 102 | Venerable Emerging Markets Equity Fund Venerable Variable Insurance Trust | 703 | 208.8K $ | 0.15 % | as of Mar 31, 2026 ↗ |
| 103 | T. Rowe Price Tax-Efficient Equity Fund T. ROWE PRICE TAX-EFFICIENT FUNDS, INC. | 650 | 206K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| 104 | Health Care Fund Rydex Series Funds | 515 | 152.9K $ | 0.79 % | as of Mar 31, 2026 ↗ |
| 105 | ULTRAEMERGING MARKETS PROFUND ProFunds | 430 | 127K $ | 0.91 % | as of Apr 30, 2026 ↗ |
| 106 | Fidelity Fundamental Emerging Markets ETF Fidelity Covington Trust | 406 | 119.9K $ | 0.30 % | as of Apr 30, 2026 ↗ |
| 107 | WisdomTree Emerging Markets Efficient Core Fund WisdomTree Trust | 273 | 81.1K $ | 0.18 % | as of Mar 31, 2026 ↗ |
| 108 | Health Care Fund Rydex Variable Trust | 270 | 80.2K $ | 0.64 % | as of Mar 31, 2026 ↗ |
| 109 | Emerging Markets 2x Strategy Fund Rydex Series Funds | 236 | 70.1K $ | 0.73 % | as of Mar 31, 2026 ↗ |
| 110 | T. Rowe Price Global Allocation Fund T. ROWE PRICE GLOBAL ALLOCATION FUND, INC. | 212 | 62.6K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| 111 | Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 209 | 62.1K $ | 0.29 % | as of Mar 31, 2026 ↗ |
| 112 | SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 203 | 60.3K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| 113 | Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust | 194 | 61.5K $ | 0.03 % | as of Feb 28, 2026 ↗ |
| 114 | World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 101 | 29.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| 115 | Fidelity Series Sustainable Emerging Markets Fund Fidelity Investment Trust | 91 | 26.9K $ | 0.13 % | as of Apr 30, 2026 ↗ |
| 116 | T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 29 | 8.6K $ | 0.06 % | as of Mar 31, 2026 ↗ |
Institutional managers
278 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 8,799,053 | 2.6B $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 4,975,181 | 1.5B $ | as of Mar 31, 2026 |
| Capital International Investors | 4,158,726 | 1.2B $ | as of Mar 31, 2026 |
| FMR LLC | 3,693,610 | 1.1B $ | as of Mar 31, 2026 |
| Capital World Investors | 1,622,687 | 481.9M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 1,034,306 | 307.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,032,298 | 306.6M $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 862,643 | 256.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 657,501 | 195.3M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 465,000 | 138.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 464,472 | 137.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 415,330 | 123.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 405,273 | 120.4M $ | as of Mar 31, 2026 |
| Baird Financial Group, Inc. | 349,651 | 103.8M $ | as of Mar 31, 2026 |
| Capital International, Inc./CA/ | 302,243 | 89.8M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 259,731 | 77.1M $ | as of Mar 31, 2026 |
| Man Group plc | 241,922 | 71.8M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 241,426 | 71.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 204,846 | 60.8M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 201,641 | 59.9M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 196,429 | 58.3M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 184,356 | 54.7M $ | as of Mar 31, 2026 |
| CAPITAL INTERNATIONAL SARL | 173,879 | 51.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 172,643 | 51.3M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 155,002 | 46M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding BEONE MEDICINES LTD". https://titelia.com/en/stocks/beone-medicines-ltd-US07725L1026